We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
94 hedge funds and large institutions have $153M invested in Larimar Therapeutics in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
17% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 30
6% more funds holding
Funds holding: 89 → 94 (+5)
1.11% more ownership
Funds ownership: 5.88% → 7% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
50% less capital invested
Capital invested by funds: $304M → $153M (-$151M)
85% less call options, than puts
Call options by funds: $5K | Put options by funds: $34K
Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
35
Reduced
30
Closed
10
Calls
$5K
Puts
$34K
Net Calls
-$29K
Net Calls Change
+$90K
Top Buyers
| 1 |
6CM
683 Capital Management
New York
|
+$11.5M |
| 2 |
BlackRock
New York
|
+$3.91M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.7M |
| 4 |
Morgan Stanley
New York
|
+$1.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.27M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.07M |
| 2 |
Millennium Management
New York
|
-$2.91M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.49M |
| 5 |
KC
Kepos Capital
New York
|
-$978K |
